vs

Side-by-side financial comparison of PRECISION BIOSCIENCES INC (DTIL) and New Gold Inc. (NGD). Click either name above to swap in a different company.

New Gold Inc. is the larger business by last-quarter revenue ($44.1M vs $34.2M, roughly 1.3× PRECISION BIOSCIENCES INC).

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

JB Hi-Fi Limited is an Australian consumer electronics retail company. It is publicly listed on the Australian Securities Exchange. Its headquarters are located in Southbank, Melbourne, Victoria.

DTIL vs NGD — Head-to-Head

Bigger by revenue
NGD
NGD
1.3× larger
NGD
$44.1M
$34.2M
DTIL

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
DTIL
DTIL
NGD
NGD
Revenue
$34.2M
$44.1M
Net Profit
$20.1M
Gross Margin
Operating Margin
36.6%
Net Margin
58.9%
Revenue YoY
5261.1%
Net Profit YoY
213.5%
EPS (diluted)
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DTIL
DTIL
NGD
NGD
Q4 25
$34.2M
Q3 25
$13.0K
$44.1M
Q2 25
$18.0K
Q1 25
$29.0K
Q4 24
$638.0K
Q3 24
$576.0K
Q2 24
$49.9M
Q1 24
$17.6M
Net Profit
DTIL
DTIL
NGD
NGD
Q4 25
$20.1M
Q3 25
$-21.8M
Q2 25
$-23.5M
Q1 25
$-20.6M
Q4 24
Q3 24
$-16.4M
Q2 24
$32.7M
Q1 24
$8.6M
Operating Margin
DTIL
DTIL
NGD
NGD
Q4 25
36.6%
Q3 25
-158976.9%
Q2 25
-121538.9%
Q1 25
-76248.3%
Q4 24
Q3 24
-3693.6%
Q2 24
48.4%
Q1 24
-23.8%
Net Margin
DTIL
DTIL
NGD
NGD
Q4 25
58.9%
Q3 25
-167476.9%
Q2 25
-130666.7%
Q1 25
-70913.8%
Q4 24
Q3 24
-2851.6%
Q2 24
65.6%
Q1 24
48.8%
EPS (diluted)
DTIL
DTIL
NGD
NGD
Q4 25
$2.62
Q3 25
$-1.84
Q2 25
$-2.13
Q1 25
$-2.21
Q4 24
Q3 24
$-2.25
Q2 24
$4.67
Q1 24
$1.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DTIL
DTIL
NGD
NGD
Cash + ST InvestmentsLiquidity on hand
$115.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$92.2M
Total Assets
$154.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DTIL
DTIL
NGD
NGD
Q4 25
$115.6M
Q3 25
$44.9M
Q2 25
$62.2M
Q1 25
$77.2M
Q4 24
$86.3M
Q3 24
$101.2M
Q2 24
$123.6M
Q1 24
$137.8M
Stockholders' Equity
DTIL
DTIL
NGD
NGD
Q4 25
$92.2M
Q3 25
$16.6M
Q2 25
$34.1M
Q1 25
$49.3M
Q4 24
$56.4M
Q3 24
$64.9M
Q2 24
$74.7M
Q1 24
$37.2M
Total Assets
DTIL
DTIL
NGD
NGD
Q4 25
$154.4M
Q3 25
$93.5M
Q2 25
$108.9M
Q1 25
$124.4M
Q4 24
$136.4M
Q3 24
$153.3M
Q2 24
$165.8M
Q1 24
$184.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DTIL
DTIL
NGD
NGD
Operating Cash FlowLast quarter
$-11.3M
Free Cash FlowOCF − Capex
$-11.3M
FCF MarginFCF / Revenue
-32.9%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-0.56×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DTIL
DTIL
NGD
NGD
Q4 25
$-11.3M
Q3 25
$-15.3M
Q2 25
$-20.3M
Q1 25
$-19.1M
Q4 24
$-58.4M
Q3 24
$-5.9M
Q2 24
$-14.9M
Q1 24
$-19.0M
Free Cash Flow
DTIL
DTIL
NGD
NGD
Q4 25
$-11.3M
Q3 25
Q2 25
$-20.3M
Q1 25
$-19.1M
Q4 24
$-58.7M
Q3 24
$-6.0M
Q2 24
$-14.9M
Q1 24
$-19.1M
FCF Margin
DTIL
DTIL
NGD
NGD
Q4 25
-32.9%
Q3 25
Q2 25
-112627.8%
Q1 25
-65917.2%
Q4 24
-9199.8%
Q3 24
-1033.2%
Q2 24
-29.9%
Q1 24
-108.4%
Capex Intensity
DTIL
DTIL
NGD
NGD
Q4 25
0.1%
Q3 25
0.0%
Q2 25
11.1%
Q1 25
220.7%
Q4 24
39.2%
Q3 24
6.8%
Q2 24
0.1%
Q1 24
0.5%
Cash Conversion
DTIL
DTIL
NGD
NGD
Q4 25
-0.56×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-0.45×
Q1 24
-2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons